Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00305565 · ClinicalTrials.gov registry record · Phase 4
Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses
A Phase 4 study, sponsored by Cyberonics.
- Completed
- Registry status
- Phase 4
- Development phase
- 331
- Enrollment target
NCT00305565 is a Phase 4 study that has completed, run by Cyberonics. The registered enrollment target is 331 participants.
The verdict
NCT00305565, a Phase 4 study, has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 331 participants
- Enrollment target
Study Summary
This is a postmarket medical device study. The objective of this study is to compare the safety and effectiveness of Vagus Nerve Stimulation (VNS) Therapy administered at different amounts of electrical charge for the treatment of patients with treatment-resistant depression (TRD).
Interventions
- DEVICE VNS Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00305565
The ClinicalTrials.gov registry entry for NCT00305565 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 331 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VNS Therapy is the first listed.
NCT00305565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00305565 about?
NCT00305565 is a clinical study titled "Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses". This is a postmarket medical device study. The objective of this study is to compare the safety and effectiveness of Vagus Nerve Stimulation (VNS) Therapy administered at different amounts of electrical charge for the treatment of patients with treatment-resistant depression (TRD).
What is the current status of trial NCT00305565?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 331 participants. The study started on 2006-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00305565?
The interventions under investigation include: VNS Therapy (DEVICE).
Who is sponsoring clinical trial NCT00305565?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.